首页|期刊导航|实用心脑肺血管病杂志|重复经颅磁刺激辅助治疗创伤性颅脑损伤患者有效性及安全性的Meta分析

重复经颅磁刺激辅助治疗创伤性颅脑损伤患者有效性及安全性的Meta分析OA

Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation in the Adjuvant Treatment of Patients with Traumatic Brain Injury:a Meta-analysis

中文摘要英文摘要

目的 系统评价重复经颅磁刺激(rTMS)辅助治疗创伤性颅脑损伤(TBI)患者的有效性及安全性.方法 计算机检索中国知网、万方数据知识服务平台、中国生物医学文献数据库、维普网、PubMed、Web of Science、Cochrane Library、Embase中关于rTMS辅助治疗TBI的中文及英文文献,检索时限为建库至2025年11月.采用Cochrane偏倚风险评估工具对纳入文献进行风险偏倚评价,采用RevMan 5.3和Stata 18.0软件进行Meta分析.结果 最终纳入29篇文献,其中中文文献26篇、英文文献3篇;总样本量2 224例,其中对照组1 032例、联合组1 192例.Meta分析结果显示,治疗后,联合组简易精神状态检查量表(MMSE)评分[均数差(MD)=3.27,95%CI(2.52~4.02)]、蒙特利尔认知评估量表(MoCA)评分[MD=3.43,95%CI(2.63~4.23)]、Fugl-Meyer运动功能评价量表(FMA)评分[MD=11.17,95%CI(7.54~14.81)]、格拉斯哥昏迷量表(GCS)评分[MD=1.99,95%CI(0.85~3.12)]、改良Barthel指数(mBI)[MD=10.05,95%CI(7.76~12.35)]、日常生活活动能力(ADL)量表评分[MD=10.83,95%CI(6.48~15.18)]、治疗总有效率[相对危险度(RR)=1.28,95%CI(1.16~1.42)]高于对照组,事件相关电位P300波幅[MD=2.00,95%CI(1.29~2.71)]大于对照组,事件相关电位P300潜伏期[MD=-22.92,95%CI(-30.77~-15.07)]、连线测验(TMT)完成时间[标准均数差(SMD)=-1.09,95%CI(-1.44~-0.74)]短于对照组(P<0.05);对照组和联合组治疗后SCWT-Stroop颜色词测试(SCWT)结果[SMD=-2.10,95%CI(-4.62~0.42)]、不良反应发生率[RR=1.86,95%CI(0.92~3.74)]比较,差异无统计学意义(P>0.05).敏感性分析结果显示,更换效应模型后,Meta分析结果无明显改变.结论 rTMS辅助治疗可有效改善TBI患者认知功能、运动功能,减轻病情严重程度,提高ADL和治疗总有效率,且安全性较高.

Objective To systematically evaluate the efficacy and safety of repetitive transcranial magnetic stimulation(rTMS)in the adjuvant treatment of patients with traumatic brain injury(TBI).Methods The Chinese and English literature about rTMS adjuvant therapy for TBI in CNKI,Wanfang Data,Chinese Biomedical Literature Database,VIP,PubMed,Web of Science,Cochrane Library and Embase were searched by computer from the establishment of the databases to November 2025.The Cochrane bias risk assessment tool was used to evaluate the quality of the included literature,and RevMan 5.3 and Stata 18.0 softwares were used for meta-analysis.Results Finally,29 literature were included,including 26 Chinese literature and 3 English literature.The total sample size was 2 224 cases,including 1 032 cases in the control group and 1 192 cases in the combined group.The meta-analysis results showed that,after treatment,Mini-Mental State Examination(MMSE)score[mean difference(MD)=3.27,95%CI(2.52-4.02)],Montreal Cognitive Assessment(MoCA)score[MD=3.43,95%CI(2.63-4.23)],Fugl-Meyer Assessment(FMA)score[MD=11.17,95%CI(7.54-14.81)],Glasgow Coma Scale(GCS)score[MD=1.99,95%CI(0.85-3.12)],modified Barthel Index(mBI)[MD=10.05,95%CI(7.76-12.35)],Activities of Daily Living(ADL)Scale score[MD=10.83,95%CI(6.48-15.18)],and the total effective rate of treatment[relative risk(RR)=1.28,95%CI(1.16-1.42)]in the combined group were higher than those in the control group,the amplitude of event-related potential P300[MD=2.00,95%CI(1.29-2.71)]was greater than that in the control group,the latency of event-related potential P300[MD=-22.92,95%CI(-30.77--15.07)]and the completion time of Trail Making Test(TMT)[standard mean difference(SMD)=-1.09,95%CI(-1.44--0.74)]were shorter than those in the control group(P<0.05).There were no statistically significant difference of Stroop Color Word Test(SCWT)results after treatment[SMD=-2.10,95%CI(-4.62-0.42)]and incidence of adverse reactions[RR=1.86,95%CI(0.92-3.74)]between the control group and the combined group(P>0.05).The results of sensitivity analysis showed that there was no significant change in the results of meta-analysis after changing the effect model.Conclusion rTMS adjuvant therapy can effectively improve the cognitive function and motor function of TBI patients,reduce the severity of the disease,improve ADL and total effective rate of treatment,and has high safety.

李玉洁;贾瑶;张腊婷;李思彤;姜雪

710038 陕西省西安市,空军军医大学唐都医院神经外科710038 陕西省西安市,空军军医大学唐都医院神经外科712046 陕西省咸阳市,陕西中医药大学护理学院710038 陕西省西安市,空军军医大学唐都医院神经外科710038 陕西省西安市,空军军医大学唐都医院神经外科

医药卫生

颅脑损伤创伤性颅脑损伤重复经颅磁刺激有效性安全性Meta分析

Craniocerebral traumaTraumatic brain injuryRepetitive transcranial magnetic stimulationEfficacySafetyMeta-analysis

《实用心脑肺血管病杂志》 2026 (7)

84-91,8

10.12114/j.issn.1008-5971.2026.00.170

评论